Orexo AB (ORX) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.091x

Based on the latest financial reports, Orexo AB (ORX) has a cash flow conversion efficiency ratio of -0.091x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-33.30 Million ≈ $-3.58 Million USD) by net assets (Skr364.70 Million ≈ $39.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Orexo AB liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Orexo AB - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Orexo AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Orexo AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Orexo AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Fortress Biotech Inc NASDAQ:FBIO	-0.202x
Definitive Healthcare Corp NASDAQ:DH	0.007x
Azaria Rental SOCIMI S.A. MC:YAZR	-0.025x
Biodesix Inc NASDAQ:BDSX	5.156x
Drilling Tools International Corp. NASDAQ:DTI	-0.026x
Vera Bradley Inc NASDAQ:VRA	-0.042x
VIVANI MED.INC. NEW O.N. F:U5P	-0.427x
The Sandesh Limited NSE:SANDESH	0.018x

Annual Cash Flow Conversion Efficiency for Orexo AB (2002–2025)

The table below shows the annual cash flow conversion efficiency of Orexo AB from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see ORX market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr490.60 Million ≈ $52.80 Million	Skr173.00 Million ≈ $18.62 Million	0.353x	+36.62%
2024-12-31	Skr-126.30 Million ≈ $-13.59 Million	Skr-32.60 Million ≈ $-3.51 Million	0.258x	+116.00%
2023-12-31	Skr58.90 Million ≈ $6.34 Million	Skr-95.00 Million ≈ $-10.22 Million	-1.613x	-99.71%
2022-12-31	Skr193.90 Million ≈ $20.87 Million	Skr-156.60 Million ≈ $-16.85 Million	-0.808x	-23.30%
2021-12-31	Skr349.60 Million ≈ $37.62 Million	Skr-229.00 Million ≈ $-24.64 Million	-0.655x	-2277.60%
2020-12-31	Skr558.50 Million ≈ $60.10 Million	Skr16.80 Million ≈ $1.81 Million	0.030x	-92.60%
2019-12-31	Skr706.40 Million ≈ $76.02 Million	Skr287.00 Million ≈ $30.89 Million	0.406x	-20.07%
2018-12-31	Skr476.10 Million ≈ $51.24 Million	Skr242.00 Million ≈ $26.04 Million	0.508x	+14.11%
2017-12-31	Skr329.10 Million ≈ $35.42 Million	Skr146.60 Million ≈ $15.78 Million	0.445x	-11.51%
2016-12-31	Skr310.30 Million ≈ $33.39 Million	Skr156.20 Million ≈ $16.81 Million	0.503x	+231.25%
2015-12-31	Skr266.46 Million ≈ $28.68 Million	Skr-102.19 Million ≈ $-11.00 Million	-0.384x	+64.19%
2014-12-31	Skr455.02 Million ≈ $48.97 Million	Skr-487.30 Million ≈ $-52.44 Million	-1.071x	+34.30%
2013-12-31	Skr161.46 Million ≈ $17.38 Million	Skr-263.20 Million ≈ $-28.32 Million	-1.630x	-1187.18%
2012-12-31	Skr191.19 Million ≈ $20.58 Million	Skr28.67 Million ≈ $3.09 Million	0.150x	+139.79%
2011-12-31	Skr311.10 Million ≈ $33.48 Million	Skr-117.23 Million ≈ $-12.62 Million	-0.377x	-310.64%
2010-12-31	Skr468.24 Million ≈ $50.39 Million	Skr-42.97 Million ≈ $-4.62 Million	-0.092x	+62.41%
2009-12-31	Skr548.66 Million ≈ $59.04 Million	Skr-133.93 Million ≈ $-14.41 Million	-0.244x	-37.04%
2008-12-31	Skr569.78 Million ≈ $61.32 Million	Skr-101.49 Million ≈ $-10.92 Million	-0.178x	+25.50%
2007-12-31	Skr671.25 Million ≈ $72.24 Million	Skr-160.49 Million ≈ $-17.27 Million	-0.239x	-206.76%
2006-12-31	Skr324.35 Million ≈ $34.91 Million	Skr-25.28 Million ≈ $-2.72 Million	-0.078x	+41.80%
2005-12-31	Skr338.91 Million ≈ $36.47 Million	Skr-45.38 Million ≈ $-4.88 Million	-0.134x	+33.29%
2004-12-31	Skr79.44 Million ≈ $8.55 Million	Skr-15.94 Million ≈ $-1.72 Million	-0.201x	+73.90%
2003-12-31	Skr35.88 Million ≈ $3.86 Million	Skr-27.59 Million ≈ $-2.97 Million	-0.769x	+5.68%
2002-12-31	Skr25.52 Million ≈ $2.75 Million	Skr-20.80 Million ≈ $-2.24 Million	-0.815x	--

About Orexo AB

ST:ORX Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$79.38 Million

Skr737.67 Million SEK

Market Cap Rank

#20191 Global

#360 in Sweden

Share Price

Skr21.00

Change (1 day)

+0.00%

52-Week Range

Skr18.00 - Skr41.60

All Time High

Skr85.70